These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2434088)

  • 1. Endocytotic internalization of alpha-2-macroglobulin: alpha-galactosidase conjugate by cultured fibroblasts derived from Fabry hemizygote.
    Osada T; Kuroda Y; Ikai A
    Biochem Biophys Res Commun; 1987 Jan; 142(1):100-6. PubMed ID: 2434088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fate of internalized alpha-2-macroglobulin: alpha-galactosidase conjugate in fibroblasts from Fabry's hemizygote.
    Osada T; Kuroda Y; Ikai A
    Biochem Biophys Res Commun; 1987 Mar; 143(3):954-8. PubMed ID: 2436620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
    Fensom AH; Benson PF; Grant AR; Jacobs L
    J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal enzyme replacement using alpha 2-macroglobulin as a transport vehicle.
    Tsuji A; Oda R; Sakiyama K; Nagamune H; Itoh K; Kase R; Sakuraba H; Suzuki Y; Matsuda Y
    J Biochem; 1994 May; 115(5):937-44. PubMed ID: 7525546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocytosis of lysosomal alpha-galactosidase A by cultured fibroblasts from patients with Fabry disease.
    Mayes JS; Cray EL; Dell VA; Scheerer JB; Sifers RN
    Am J Hum Genet; 1982 Jul; 34(4):602-10. PubMed ID: 6285697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of electron-dense lamellar material from Fabry's disease fibroblasts after enzyme replacement.
    Sifers RN; Mayes JS; Nordquist RE
    Hum Genet; 1983; 65(1):85-7. PubMed ID: 6315565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
    Mayes JS; Scheerer JB; Sifers RN; Donaldson ML
    Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Fabry's disease heterozygotes by enzyme analysis in single fibroblasts after cell sorting.
    Jongkind JF; Verkerk A; Niermeijer MF
    Clin Genet; 1983 Apr; 23(4):261-6. PubMed ID: 6303650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual activity of alpha-galactosidase A in Fabry's disease.
    Romeo G; D'Urso M; Pisacane A; Blum E; De Falco A; Ruffilli A
    Biochem Genet; 1975 Oct; 13(9-10):615-28. PubMed ID: 812485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme replacement in Fabry endothelial cells and fibroblasts: uptake experiments and electron microscopical studies.
    Hasholt L; Wandall A; Sørensen SA
    Clin Genet; 1988 May; 33(5):360-71. PubMed ID: 2837353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells.
    Johnson DL; Desnick RJ
    Biochim Biophys Acta; 1978 Jan; 538(2):195-204. PubMed ID: 23178
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of the multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase in the normal and in Fabry's disease.
    Beyer E; Schono N; Kozlova I; Wiederschain G
    Biochim Biophys Acta; 1990 May; 1038(3):386-9. PubMed ID: 2160280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and degradation of alpha 2-macroglobulin by cultured fibroblasts.
    Mosher DF; Vaheri A
    Biochim Biophys Acta; 1980 Jan; 627(2):113-22. PubMed ID: 6153143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and Gene Therapy of Anderson-Fabry Disease.
    Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
    Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.
    Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K
    Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients.
    Massaccesi L; Burlina A; Baquero CJ; Goi G; Burlina AP; Tettamanti G
    Clin Biochem; 2011 Jul; 44(10-11):916-21. PubMed ID: 21515249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabry's disease with partially deficient hydrolysis of ceramide trihexoside.
    Kobayashi T; Kira J; Shinnoh N; Goto I; Kuroiwa Y
    J Neurol Sci; 1985 Feb; 67(2):179-85. PubMed ID: 2984338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer.
    Ziegler RJ; Yew NS; Li C; Cherry M; Berthelette P; Romanczuk H; Ioannou YA; Zeidner KM; Desnick RJ; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(10):1667-82. PubMed ID: 10428212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of ceramide trihexoside in cultured skin fibroblasts from Fabry's patients, carriers and normal controls.
    Kobayashi T; Shinnoh N; Kuroiwa Y
    J Neurol Sci; 1984 Aug; 65(2):169-77. PubMed ID: 6090593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ConA-mediated binding and uptake of purified alpha-galactosidase A in Fabry fibroblasts.
    Hasholt L; Sørensen SA
    Exp Cell Res; 1983 Oct; 148(2):405-11. PubMed ID: 6313412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.